HYDROXYCHLOROQUINE Drug Patent Profile
✉ Email this page to a colleague
When do Hydroxychloroquine patents expire, and when can generic versions of Hydroxychloroquine launch?
Hydroxychloroquine is a drug marketed by Accord Hlthcare, Alkaloida Zrt, Amneal Pharms Co, Appco, Aurobindo Pharma Usa, Chartwell Rx, Creekwood Pharms, Hikma Pharms, Ipca Labs Ltd, Laurus, Sandoz, Senores Pharms, Teva Pharms, Watson Labs, and Zydus Pharms Usa Inc. and is included in fifteen NDAs.
The generic ingredient in HYDROXYCHLOROQUINE is hydroxychloroquine sulfate. There are fifteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the hydroxychloroquine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydroxychloroquine
A generic version of HYDROXYCHLOROQUINE was approved as hydroxychloroquine sulfate by TEVA PHARMS on September 30th, 1994.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HYDROXYCHLOROQUINE?
- What are the global sales for HYDROXYCHLOROQUINE?
- What is Average Wholesale Price for HYDROXYCHLOROQUINE?
Summary for HYDROXYCHLOROQUINE
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 15 |
| Drug Prices: | Drug price information for HYDROXYCHLOROQUINE |
| Drug Sales Revenues: | Drug sales revenues for HYDROXYCHLOROQUINE |
| DailyMed Link: | HYDROXYCHLOROQUINE at DailyMed |
US Patents and Regulatory Information for HYDROXYCHLOROQUINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | TABLET;ORAL | 213342-002 | Aug 18, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Senores Pharms | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | TABLET;ORAL | 212902-001 | May 14, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Appco | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | TABLET;ORAL | 210441-002 | Sep 19, 2022 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Accord Hlthcare | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | TABLET;ORAL | 213342-004 | Aug 18, 2021 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
